Early Clinical Outcomes Following Relex Smile Pro Using The Visumax 800 In Terms Of Safety, Efficacy And Intraoperative Complications

Published 2022 - 40th Congress of the ESCRS

Reference: FPM07.09 | Type: Free paper | DOI: 10.82333/eq0w-xm51

Authors: Supriya Samak Sriganesh* ¹ , Sri Ganesh ² , Sheetal Brar ²

¹Phaco and Refractive Surgery,Nethradhama Superspeciality Eye Hospital,Bangalore,India;Phaco and Refractive Surgery,Nethradhama Superspeciality Eye Hospital,Bangalore,India, ²Phaco and Refractive Surgery,Nethradhama Superspeciality Eye Hospital,Bangalore,India

Purpose

To evaluate the early clinical outcomes following ReLEx SMILE PRO using the Visumax 800 in terms of safety, efficacy and intraoperative complications

Setting

Nethradhama Superspecialty Eye Hospital, Bangalore

Methods

A total of 136 eyes of 69 patients (27.00 ± 4.37 years; mean age ± standard deviation) with a mean spherical equivalent of -4.39 ± 1.76 underwent the ReLEx SMILE Pro procedure using the Visumax 800 machine for correction of myopia. The clinical outcomes were evaluated on post operative day 1 and 2 weeks with respect to safety, efficacy and adverse events.

Results

The average pre operative corrected distance visual acuity was -0.08 ± 0.04 logMar, average post operative 2 weeks uncorrected distance visual acuity -0.08 ± 0.06 logMar and corrected post operative distance visual acuity was -0.09 ± 0.05. The efficacy index was found to be 1.00 and safety index 1.01. The pre operative OSI was 0.57 ± 0.51

and post operative week 2 OSI was 0.77 ± 0.22 (< 0.001). No complications were observed in any of the cases.

Conclusions

2 week post-op results with the VisuMax 800 demonstrate excellent correction and good visual acuity in terms of efficacy. No eyes had more than one line loss of CDVA, demonstrating a good safety profile. Quality of vision and interface clarity showed minimal increase in scatter, which is expected to improve over time.